Engineers Gate Manager LP Iveric Bio, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$18.67 - $24.56 $365,819 - $481,228
19,594 Added 120.37%
35,872 $872,000
Q4 2022

Feb 14, 2023
BUY
$17.24 - $23.95 $280,632 - $389,858
16,278 New
16,278 $348,000
Q2 2020

Aug 17, 2020
SELL
$3.06 - $6.6 $41,616 - $89,760
-13,600 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$2.83 - $8.44 $38,488 - $114,784
13,600 New
13,600 $47,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email